Reddy Aramati Bindu Madhava, Kaur Kiranpreet, Mandal Anil Kumar, Panicker Shirly George, Thomas Ravi, Hasnain Seyed Ehtesham, Balasubramanian Dorairajan, Chakrabarti Subhabrata
Kallam Anji Reddy Molecular Genetics Laboratory, L.V. Prasad Eye Institute, Hyderabad, India.
Mol Vis. 2004 Sep 30;10:696-702.
The human Cytochrome P450 gene CYP1B1 has been implicated in primary congenital glaucoma worldwide. The aim of this study was to understand the role of CYP1B1 mutations in causing primary congenital glaucoma in Indian populations.
The study included 64 new and unrelated cases of primary congenital glaucoma from different ethnic groups of India. Direct sequencing screened the coding and the promoter regions of CYP1B1.
Sixteen pathogenic mutations were observed in 24 cases, of which 7 were novel. These included two frameshift mutations leading to deletions of 23 bp (g.3905del23bp) and 2 bp (g.7900-7901delCG) in exons II and III, respectively. Four novel missense mutations viz. A115P, M132R, Q144P, S239R were noted in exon II, and one in exon III (G466D), whose residue is a part of the "signature sequence" (NH2-FXXGXXXCXG-COOH) and is present in all heme binding cytochromes. Overall, CYP1B1 was involved in 37.50% (24/64) cases and homozygosity of the mutant allele was seen in 29.68% (19/64) and compound heterozygosity in 3.12% (2/64) of the cases, respectively. The frequency of CYP1B1 mutations was comparatively lower than Saudi Arabian, Slovakian Gypsys, and Turkish populations, largely due to genetic heterogeneity and ethnic diversities in Indian populations. Genotype-phenotype correlation indicated variable prognosis that could be due to the type of mutation, leading to alteration of CYP1B1 protein.
This study provides a mutation spectrum of CYP1B1 causing primary congenital glaucoma in Indian populations that has implications in devising molecular diagnostics for rapid screening.
人类细胞色素P450基因CYP1B1在全球范围内都与原发性先天性青光眼有关。本研究的目的是了解CYP1B1突变在印度人群原发性先天性青光眼中的作用。
该研究纳入了64例来自印度不同种族的新发且无亲缘关系的原发性先天性青光眼病例。直接测序法筛查了CYP1B1的编码区和启动子区域。
在24例病例中观察到16个致病突变,其中7个是新发现的。这些突变包括两个移码突变,分别导致外显子II和III中缺失23 bp(g.3905del23bp)和2 bp(g.7900 - 7901delCG)。在外显子II中发现了四个新的错义突变,即A115P、M132R、Q144P、S239R,外显子III中有一个(G466D),其残基是“特征序列”(NH2 - FXXGXXXCXG - COOH)的一部分,存在于所有血红素结合细胞色素中。总体而言,CYP1B1涉及37.50%(24/64)的病例,突变等位基因的纯合性在29.68%(19/64)的病例中出现,复合杂合性在3.12%(2/64)的病例中出现。CYP1B1突变的频率相对低于沙特阿拉伯、斯洛伐克吉普赛人和土耳其人群,这主要是由于印度人群的遗传异质性和种族多样性。基因型 - 表型相关性表明预后存在差异,这可能是由于突变类型导致CYP1B1蛋白改变所致。
本研究提供了CYP1B1在印度人群中导致原发性先天性青光眼的突变谱,这对设计用于快速筛查的分子诊断方法具有重要意义。